Arbutus Reports Fourth Quarter and Year-end 2018 Financial Results and Describes Recent Clinical Accomplishments and Key 2019 Objectives

Go back to Arbutus Reports Fourth Quarter and Year-end 2018 Financial Results and Describes Recent Clinical Accomplishments and Key 2019 Objectives
(NASDAQ: ABUS) Delayed: 5.00 --0 (-0%)
Previous Close $5.00    52 Week High $5.88 
Open $5.00    52 Week Low $2.65 
Day High $5.00    P/E N/A 
Day Low $5.00    EPS $0.00 
Volume 17       

(NASDAQ: ABUS) Delayed: 5.00 --0 (-0%)
Previous Close $5.00    52 Week High $5.88 
Open $5.00    52 Week Low $2.65 
Day High $5.00    P/E N/A 
Day Low $5.00    EPS $0.00 
Volume 17